NCT03099174 2025-06-24This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast CancerBoehringer IngelheimPhase 1 Completed133 enrolled 26 charts
NCT06341283 2024-05-10A Retrospective Real-world Study of Abemaciclib in HR+ Breast CancerThe Affiliated Hospital of Qingdao UniversityNot yet recruiting200 enrolled